These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30505863)

  • 1. Stakeholder analysis of Iran's health insurance system.
    Heydari M; Seyedin H; Jafari M; Dehnavieh R
    J Educ Health Promot; 2018; 7():135. PubMed ID: 30505863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.
    Olyaaeemanesh A; Jaafaripooyan E; Abdollahiasl A; Davari M; Mousavi SM; Delpasand M
    Health Res Policy Syst; 2021 Dec; 19(1):150. PubMed ID: 34949207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financing of physical rehabilitation services in Iran: a stakeholder and social network analysis.
    Shahabi S; Ahmadi Teymourlouy A; Shabaninejad H; Kamali M; Lankarani KB
    BMC Health Serv Res; 2020 Jul; 20(1):599. PubMed ID: 32611339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated early childhood development policy in Iran: a stakeholder analysis.
    Atashbahar O; Sari AA; Takian A; Olyaeemanesh A; Mohamadi E; Barakati SH
    BMC Health Serv Res; 2021 Sep; 21(1):971. PubMed ID: 34526031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of charities in Iran's health care system: a qualitative study on problems and executive/legal/supportive requirements.
    Gholamzadeh Nikjoo R; Partovi Y; Joudyian N
    BMC Health Serv Res; 2021 Feb; 21(1):181. PubMed ID: 33632197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2012-2025 Roadmap of I.R.Iran's Disaster Health Management.
    Ardalan A; Rajaei MH; Masoumi G; Azin A; Zonoobi V; Sarvar M; Vaskoei Eshkevari K; Ahmadnezhad E; Jafari G
    PLoS Curr; 2012 Jul; 4():e4f93005fbcb34. PubMed ID: 22953239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining health insurance funds in a fragmented context: what kind of challenges should be considered?
    Bazyar M; Rashidian A; Alipouri Sakha M; Vaez Mahdavi MR; Doshmangir L
    BMC Health Serv Res; 2020 Jan; 20(1):26. PubMed ID: 31915003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who really counts in Iran's National Food Assistance Program? Lessons from multi-stakeholder processes in the wicked policy area of food security.
    Pourghaderi M; Omidvar N; Takian A; Ville AS; Kangarani HM; Eini-Zinab H
    Cad Saude Publica; 2022; 38(1):e00341820. PubMed ID: 35043889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nongovernmental organizations in Iran's health system: What do they do and what can they do?
    Rajabi M; Ebrahimi P; Aryankhesal A
    J Educ Health Promot; 2022; 11():101. PubMed ID: 35573612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholders analysis of COVID-19 management and control: a case of Iran.
    Mohamadian M; Nasiri T; Bahadori M; Jalilian H
    BMC Public Health; 2022 Oct; 22(1):1909. PubMed ID: 36229818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surprising decline in Iran's growth rates.
    Roudi F
    Popul Today; 1997 Nov; 25(11):4. PubMed ID: 12321257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators of improving the function of nongovernmental organizations (NGOs) in Iran's health system.
    Rajabi M; Ebrahimi P; Aryankhesal A
    J Educ Health Promot; 2023; 12():147. PubMed ID: 37404908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholder analysis of childhood obesity prevention policies in Iran.
    Taghizadeh S; Zarnag RK; Farhangi MA
    Arch Public Health; 2021 Mar; 79(1):36. PubMed ID: 33731204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stakeholders analysis of merging social health insurance funds in Iran: what kind of interests they may gain or lose?
    Bazyar M; Rashidian A; Sakha MA; Doshmangir L; Rahimi N; Ranjbar M; Sagha Abolfazl SF; Tabatabaei Lotfi SM; Olyaeemanesh A
    Int J Health Plann Manage; 2019 Jan; 34(1):157-176. PubMed ID: 30156713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal Health Insurance Coverage in Vietnam: A Stakeholder Analysis From Policy Proposal (1989) to Implementation (2014).
    Hoang CK; Hill P; Nguyen HT
    J Public Health Manag Pract; 2018; 24 Suppl 2():S52-S59. PubMed ID: 29369257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intersectoral collaboration in the management of non-communicable disease's risk factors in Iran: stakeholders and social network analysis.
    Bakhtiari A; Takian A; Majdzadeh R; Ostovar A; Afkar M; Rostamigooran N
    BMC Public Health; 2022 Sep; 22(1):1669. PubMed ID: 36056315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network analysis of Iranian's health insurance ecosystem before and after the introduction of Universal Health Insurance law.
    Rahimisadegh R; Noori Hekmat S; Mehrolhassani MH; Jafari Sirizi M
    Glob Health Res Policy; 2023 May; 8(1):16. PubMed ID: 37218002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging Sub-national Collaboration and Influence for Improving Animal Health Surveillance and Response: A Stakeholder Mapping in Tanzania.
    George J; Häsler B; Komba EVG; Sindato C; Rweyemamu M; Kimera SI; Mlangwa JED
    Front Vet Sci; 2021; 8():738888. PubMed ID: 34966802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study.
    Ebadi Fardazar F; Sarabi Asiabar A; Safari H; Asgari M; Saber A; Ebadi Fard Azar AA
    Risk Manag Healthc Policy; 2019; 12():199-208. PubMed ID: 31807100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.